

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 7.03122271 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.85318990 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.27440505 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 6.17718377 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.99422810 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.68961522 |
| 7 | vocalization behavior (GO:0071625) | 5.66629609 |
| 8 | glutamate secretion (GO:0014047) | 5.52959735 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.42700367 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.31144654 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.30123377 |
| 12 | cerebellar granule cell differentiation (GO:0021707) | 5.07783872 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.00986611 |
| 14 | protein localization to synapse (GO:0035418) | 4.99806263 |
| 15 | exploration behavior (GO:0035640) | 4.89840366 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.89499072 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.82963728 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.67264875 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 4.64262324 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.61373095 |
| 21 | gamma-aminobutyric acid transport (GO:0015812) | 4.57667023 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 4.49230845 |
| 23 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.39122826 |
| 24 | neuronal action potential propagation (GO:0019227) | 4.35367362 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.26080065 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.23290484 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.22465916 |
| 28 | amino acid import (GO:0043090) | 4.19299151 |
| 29 | proline transport (GO:0015824) | 4.17240720 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 4.14212788 |
| 31 | long-term memory (GO:0007616) | 4.10235993 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.06695904 |
| 33 | positive regulation of membrane potential (GO:0045838) | 3.98785006 |
| 34 | * glutamate receptor signaling pathway (GO:0007215) | 3.96198531 |
| 35 | neurotransmitter transport (GO:0006836) | 3.95064599 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.93862647 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.92882381 |
| 38 | regulation of synapse maturation (GO:0090128) | 3.87185123 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86774106 |
| 40 | glycine transport (GO:0015816) | 3.85530295 |
| 41 | neuromuscular process controlling posture (GO:0050884) | 3.82349058 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.76626454 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.76371378 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.75986022 |
| 45 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.73616282 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.73236883 |
| 47 | neuromuscular process controlling balance (GO:0050885) | 3.73077701 |
| 48 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.71577664 |
| 49 | response to pheromone (GO:0019236) | 3.66293924 |
| 50 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.64297881 |
| 51 | * cellular potassium ion homeostasis (GO:0030007) | 3.63550503 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.62393688 |
| 53 | central nervous system myelination (GO:0022010) | 3.61626093 |
| 54 | axon ensheathment in central nervous system (GO:0032291) | 3.61626093 |
| 55 | regulation of neurotransmitter levels (GO:0001505) | 3.61445623 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.58782645 |
| 57 | regulation of synaptic plasticity (GO:0048167) | 3.58663532 |
| 58 | * sodium ion export (GO:0071436) | 3.56502969 |
| 59 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.52976734 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.51900616 |
| 61 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.46086887 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.44257773 |
| 63 | auditory behavior (GO:0031223) | 3.43618709 |
| 64 | response to auditory stimulus (GO:0010996) | 3.42990067 |
| 65 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42823738 |
| 66 | neuromuscular synaptic transmission (GO:0007274) | 3.41226547 |
| 67 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.39836897 |
| 68 | regulation of vesicle fusion (GO:0031338) | 3.39012754 |
| 69 | regulation of ARF protein signal transduction (GO:0032012) | 3.38622713 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.37285754 |
| 71 | dendrite morphogenesis (GO:0048813) | 3.36665566 |
| 72 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.36317189 |
| 73 | prepulse inhibition (GO:0060134) | 3.35180036 |
| 74 | neuron recognition (GO:0008038) | 3.34652056 |
| 75 | long-term synaptic potentiation (GO:0060291) | 3.34171099 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33786437 |
| 77 | dendritic spine organization (GO:0097061) | 3.32619245 |
| 78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.32126885 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.31383901 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.31079789 |
| 81 | cell differentiation in hindbrain (GO:0021533) | 3.29325025 |
| 82 | postsynaptic membrane organization (GO:0001941) | 3.28230827 |
| 83 | regulation of dendritic spine development (GO:0060998) | 3.25988012 |
| 84 | membrane depolarization during action potential (GO:0086010) | 3.24265693 |
| 85 | cerebellar Purkinje cell layer development (GO:0021680) | 3.20496285 |
| 86 | cell migration in hindbrain (GO:0021535) | 3.19622233 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18901211 |
| 88 | L-amino acid import (GO:0043092) | 3.17717948 |
| 89 | acidic amino acid transport (GO:0015800) | 3.16333795 |
| 90 | * potassium ion homeostasis (GO:0055075) | 3.16151958 |
| 91 | neurotransmitter uptake (GO:0001504) | 3.16092942 |
| 92 | presynaptic membrane organization (GO:0097090) | 3.15850717 |
| 93 | vesicle transport along microtubule (GO:0047496) | 3.15606160 |
| 94 | detection of calcium ion (GO:0005513) | 3.15347549 |
| 95 | innervation (GO:0060384) | 3.15332069 |
| 96 | establishment of mitochondrion localization (GO:0051654) | 3.14397358 |
| 97 | membrane depolarization (GO:0051899) | 3.13705650 |
| 98 | * cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.13544723 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.12368979 |
| 100 | mating behavior (GO:0007617) | 3.12326963 |
| 101 | establishment of synaptic vesicle localization (GO:0097480) | 3.12113381 |
| 102 | synaptic vesicle transport (GO:0048489) | 3.12113381 |
| 103 | vesicle docking involved in exocytosis (GO:0006904) | 3.11780614 |
| 104 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.11265631 |
| 105 | positive regulation of dendritic spine development (GO:0060999) | 3.09647404 |
| 106 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.09093054 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08765018 |
| 108 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.07471955 |
| 109 | neuromuscular process (GO:0050905) | 3.07432418 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 3.05530467 |
| 111 | social behavior (GO:0035176) | 3.04784369 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 3.04784369 |
| 113 | * cell communication by electrical coupling (GO:0010644) | 3.04452700 |
| 114 | regulation of synaptic transmission (GO:0050804) | 3.03963681 |
| 115 | axonal fasciculation (GO:0007413) | 3.03654429 |
| 116 | neuronal ion channel clustering (GO:0045161) | 3.03183561 |
| 117 | synapse assembly (GO:0007416) | 3.01544402 |
| 118 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.00933685 |
| 119 | behavioral defense response (GO:0002209) | 3.00500349 |
| 120 | behavioral fear response (GO:0001662) | 3.00500349 |
| 121 | synaptic transmission (GO:0007268) | 3.00429834 |
| 122 | axon cargo transport (GO:0008088) | 2.99114532 |
| 123 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98230958 |
| 124 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.98228081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.77397236 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08478821 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.05607356 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04382845 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02087056 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.95480851 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.90749988 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.84323822 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74424961 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74424961 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66176489 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63410131 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59366954 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51817425 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51678082 |
| 16 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.46387447 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.45720760 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.45555130 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42415416 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.39384775 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38334329 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36411373 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22839594 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16327899 |
| 25 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.14776289 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02282743 |
| 27 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01963537 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.89503704 |
| 29 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86801269 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80933742 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74919281 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56265401 |
| 33 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.49194813 |
| 34 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.47771956 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46384508 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45498199 |
| 37 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.39652887 |
| 38 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.39168030 |
| 39 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33689310 |
| 40 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32306428 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30752877 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30068146 |
| 43 | * AR_19668381_ChIP-Seq_PC3_Human | 1.27016673 |
| 44 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.25590915 |
| 45 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24981754 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23426427 |
| 47 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23168940 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22762216 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19685891 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19149528 |
| 51 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18880198 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18672524 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16931808 |
| 54 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16493301 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16089468 |
| 56 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15831536 |
| 57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14807984 |
| 58 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14704457 |
| 59 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12514955 |
| 60 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.11753275 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.11268179 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11144165 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11010517 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09970376 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09794633 |
| 66 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05020607 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04607388 |
| 68 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.04331426 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01295131 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00811267 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99783357 |
| 72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99617273 |
| 73 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98598415 |
| 74 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98544818 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.98155413 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98067740 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97186056 |
| 78 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96709218 |
| 79 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96395052 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95680312 |
| 81 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95478545 |
| 82 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95321976 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95160001 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94269627 |
| 85 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94121101 |
| 86 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.93769538 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91755864 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91725465 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91441429 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90846323 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90534923 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89089367 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88814218 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88738717 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88616989 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88169533 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87866103 |
| 98 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87566956 |
| 99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87332641 |
| 100 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87327191 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86524168 |
| 102 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86302150 |
| 103 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.86174931 |
| 104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86047261 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85849581 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85110028 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84887266 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84290235 |
| 109 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.82734523 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82706238 |
| 111 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81201439 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80979336 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80375967 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80317389 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80307043 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80210599 |
| 117 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.79774645 |
| 118 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79373774 |
| 119 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78798119 |
| 120 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.77248190 |
| 121 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.77086981 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76940999 |
| 123 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.75443256 |
| 124 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.72898585 |
| 125 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72657192 |
| 126 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.70721837 |
| 127 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70053737 |
| 128 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.68142428 |
| 129 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.67838558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.03371718 |
| 2 | MP0003880_abnormal_central_pattern | 4.63442955 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.35657327 |
| 4 | MP0004270_analgesia | 3.67052427 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.40965913 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.37607736 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.34693999 |
| 8 | MP0009046_muscle_twitch | 3.33174450 |
| 9 | * MP0002064_seizures | 3.25165863 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.84062084 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.74811630 |
| 12 | MP0002822_catalepsy | 2.66655158 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.66633730 |
| 14 | MP0001486_abnormal_startle_reflex | 2.64355179 |
| 15 | MP0002272_abnormal_nervous_system | 2.64053378 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.26675278 |
| 17 | MP0008569_lethality_at_weaning | 2.15126225 |
| 18 | MP0002736_abnormal_nociception_after | 2.02558139 |
| 19 | MP0003329_amyloid_beta_deposits | 2.01713418 |
| 20 | MP0001440_abnormal_grooming_behavior | 1.99014210 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.98901397 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.95493984 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.93644157 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.93440360 |
| 25 | MP0001970_abnormal_pain_threshold | 1.92531836 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.90500267 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.86578713 |
| 28 | MP0004858_abnormal_nervous_system | 1.84852109 |
| 29 | MP0002184_abnormal_innervation | 1.80919620 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.72895196 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.68071928 |
| 32 | MP0004924_abnormal_behavior | 1.68071928 |
| 33 | MP0004885_abnormal_endolymph | 1.68047185 |
| 34 | MP0000778_abnormal_nervous_system | 1.66287955 |
| 35 | MP0003879_abnormal_hair_cell | 1.62332830 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.62034648 |
| 37 | MP0000955_abnormal_spinal_cord | 1.61720432 |
| 38 | MP0001984_abnormal_olfaction | 1.57182737 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.54643497 |
| 40 | * MP0002882_abnormal_neuron_morphology | 1.49395288 |
| 41 | MP0003123_paternal_imprinting | 1.48477010 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.46566605 |
| 43 | MP0003633_abnormal_nervous_system | 1.45955366 |
| 44 | * MP0002066_abnormal_motor_capabilities/c | 1.44847562 |
| 45 | MP0003787_abnormal_imprinting | 1.44624872 |
| 46 | MP0004142_abnormal_muscle_tone | 1.32954348 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.31150310 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.26814566 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.23974317 |
| 50 | MP0003631_nervous_system_phenotype | 1.21746661 |
| 51 | MP0002229_neurodegeneration | 1.19424387 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.16634225 |
| 53 | MP0003122_maternal_imprinting | 1.14008809 |
| 54 | MP0003075_altered_response_to | 1.11156092 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.10965871 |
| 56 | * MP0002152_abnormal_brain_morphology | 1.10653150 |
| 57 | MP0002090_abnormal_vision | 1.09944068 |
| 58 | MP0003690_abnormal_glial_cell | 1.06618381 |
| 59 | MP0008872_abnormal_physiological_respon | 1.05372963 |
| 60 | MP0003283_abnormal_digestive_organ | 1.04610043 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 0.99583601 |
| 62 | MP0001905_abnormal_dopamine_level | 0.99505495 |
| 63 | MP0000751_myopathy | 0.99428537 |
| 64 | MP0002069_abnormal_eating/drinking_beha | 0.96963670 |
| 65 | MP0001529_abnormal_vocalization | 0.96847518 |
| 66 | MP0001177_atelectasis | 0.96832704 |
| 67 | MP0000604_amyloidosis | 0.96203313 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.91357991 |
| 69 | MP0003632_abnormal_nervous_system | 0.91131519 |
| 70 | MP0005394_taste/olfaction_phenotype | 0.90234174 |
| 71 | MP0005499_abnormal_olfactory_system | 0.90234174 |
| 72 | * MP0003634_abnormal_glial_cell | 0.89404694 |
| 73 | MP0000013_abnormal_adipose_tissue | 0.89027750 |
| 74 | MP0008874_decreased_physiological_sensi | 0.88975918 |
| 75 | MP0004233_abnormal_muscle_weight | 0.88807155 |
| 76 | MP0000920_abnormal_myelination | 0.88398010 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 0.87959643 |
| 78 | MP0004147_increased_porphyrin_level | 0.86683005 |
| 79 | MP0001346_abnormal_lacrimal_gland | 0.82020672 |
| 80 | MP0002752_abnormal_somatic_nervous | 0.81250264 |
| 81 | MP0005253_abnormal_eye_physiology | 0.79442015 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.79260904 |
| 83 | MP0005535_abnormal_body_temperature | 0.78902785 |
| 84 | MP0004085_abnormal_heartbeat | 0.78747849 |
| 85 | MP0004742_abnormal_vestibular_system | 0.78592901 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.77591388 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.74166327 |
| 88 | MP0001963_abnormal_hearing_physiology | 0.73081396 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.72184046 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.71360634 |
| 91 | MP0005409_darkened_coat_color | 0.71038912 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.70709986 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.70316896 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.70215752 |
| 95 | MP0004130_abnormal_muscle_cell | 0.68309725 |
| 96 | MP0003121_genomic_imprinting | 0.67722636 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.66998394 |
| 98 | MP0000579_abnormal_nail_morphology | 0.66117716 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.62584390 |
| 100 | MP0004510_myositis | 0.59785397 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.58382831 |
| 102 | MP0001188_hyperpigmentation | 0.58267324 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.58226145 |
| 104 | MP0010769_abnormal_survival | 0.56431105 |
| 105 | MP0004043_abnormal_pH_regulation | 0.55020827 |
| 106 | MP0002653_abnormal_ependyma_morphology | 0.53187179 |
| 107 | MP0010770_preweaning_lethality | 0.52866548 |
| 108 | MP0002082_postnatal_lethality | 0.52866548 |
| 109 | MP0010768_mortality/aging | 0.52625521 |
| 110 | MP0003861_abnormal_nervous_system | 0.52587290 |
| 111 | MP0001943_abnormal_respiration | 0.51881513 |
| 112 | * MP0003956_abnormal_body_size | 0.50317100 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.45168286 |
| 114 | MP0002873_normal_phenotype | 0.42841974 |
| 115 | MP0000026_abnormal_inner_ear | 0.42781763 |
| 116 | MP0000747_muscle_weakness | 0.42602266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.19321073 |
| 2 | Focal motor seizures (HP:0011153) | 6.95778035 |
| 3 | Visual hallucinations (HP:0002367) | 5.84523867 |
| 4 | Focal seizures (HP:0007359) | 5.65141847 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.71665602 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.68720253 |
| 7 | Action tremor (HP:0002345) | 4.54901870 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.27368999 |
| 9 | Febrile seizures (HP:0002373) | 4.26586790 |
| 10 | Absence seizures (HP:0002121) | 4.10149518 |
| 11 | Atonic seizures (HP:0010819) | 4.08929607 |
| 12 | Ankle clonus (HP:0011448) | 4.02567964 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.86390036 |
| 14 | Dialeptic seizures (HP:0011146) | 3.65936187 |
| 15 | Dysdiadochokinesis (HP:0002075) | 3.49930878 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.47360307 |
| 17 | Poor eye contact (HP:0000817) | 3.45198637 |
| 18 | Abnormality of the lower motor neuron (HP:0002366) | 3.40913921 |
| 19 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.37231565 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.36663545 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 3.34681873 |
| 22 | Broad-based gait (HP:0002136) | 3.30666631 |
| 23 | Papilledema (HP:0001085) | 3.28419267 |
| 24 | Dysmetria (HP:0001310) | 3.22813857 |
| 25 | * Depression (HP:0000716) | 3.21673319 |
| 26 | Impaired social interactions (HP:0000735) | 3.18732376 |
| 27 | Abnormal social behavior (HP:0012433) | 3.18732376 |
| 28 | Genetic anticipation (HP:0003743) | 3.16377681 |
| 29 | Abnormal eating behavior (HP:0100738) | 3.15261509 |
| 30 | Truncal ataxia (HP:0002078) | 3.10313291 |
| 31 | Ventricular fibrillation (HP:0001663) | 2.99080272 |
| 32 | Intention tremor (HP:0002080) | 2.93044913 |
| 33 | Impaired smooth pursuit (HP:0007772) | 2.88859255 |
| 34 | Hemiparesis (HP:0001269) | 2.80938209 |
| 35 | Urinary urgency (HP:0000012) | 2.80405503 |
| 36 | Spastic gait (HP:0002064) | 2.80370939 |
| 37 | Central scotoma (HP:0000603) | 2.74009718 |
| 38 | * Anxiety (HP:0000739) | 2.70671464 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.70519238 |
| 40 | Diplopia (HP:0000651) | 2.70519238 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.69422317 |
| 42 | Scanning speech (HP:0002168) | 2.66593179 |
| 43 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.63132953 |
| 44 | Sleep apnea (HP:0010535) | 2.62964885 |
| 45 | * Postural instability (HP:0002172) | 2.61948483 |
| 46 | Dysmetric saccades (HP:0000641) | 2.60606241 |
| 47 | Insomnia (HP:0100785) | 2.59769292 |
| 48 | Progressive inability to walk (HP:0002505) | 2.53193172 |
| 49 | Peripheral hypomyelination (HP:0007182) | 2.49603168 |
| 50 | Cerebral inclusion bodies (HP:0100314) | 2.49254299 |
| 51 | Amblyopia (HP:0000646) | 2.46855647 |
| 52 | Spastic tetraparesis (HP:0001285) | 2.43965011 |
| 53 | Stereotypic behavior (HP:0000733) | 2.42722118 |
| 54 | Status epilepticus (HP:0002133) | 2.41504722 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.39716525 |
| 56 | Annular pancreas (HP:0001734) | 2.39494598 |
| 57 | Pointed chin (HP:0000307) | 2.37059318 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.34682388 |
| 59 | Megalencephaly (HP:0001355) | 2.34270224 |
| 60 | * Torticollis (HP:0000473) | 2.32580589 |
| 61 | Diminished motivation (HP:0000745) | 2.29555230 |
| 62 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.28723887 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.27625721 |
| 64 | Clonus (HP:0002169) | 2.27196409 |
| 65 | * Bradykinesia (HP:0002067) | 2.26567935 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.26091094 |
| 67 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25352852 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25075105 |
| 69 | Impaired vibratory sensation (HP:0002495) | 2.24930746 |
| 70 | CNS hypomyelination (HP:0003429) | 2.24044460 |
| 71 | Agitation (HP:0000713) | 2.21830523 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.17987150 |
| 73 | * Focal dystonia (HP:0004373) | 2.17776992 |
| 74 | Hyperventilation (HP:0002883) | 2.17629383 |
| 75 | Polyphagia (HP:0002591) | 2.14906831 |
| 76 | Generalized myoclonic seizures (HP:0002123) | 2.13540802 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.12607521 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.10600312 |
| 79 | Limb dystonia (HP:0002451) | 2.09796822 |
| 80 | Bundle branch block (HP:0011710) | 2.07671244 |
| 81 | Pheochromocytoma (HP:0002666) | 2.07099376 |
| 82 | Abnormality of macular pigmentation (HP:0008002) | 2.05700484 |
| 83 | Abnormality of saccadic eye movements (HP:0000570) | 2.05036860 |
| 84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.03770537 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.03770537 |
| 86 | Heart block (HP:0012722) | 2.02560067 |
| 87 | Lower limb asymmetry (HP:0100559) | 2.02201907 |
| 88 | Abnormal EKG (HP:0003115) | 2.01699508 |
| 89 | Termporal pattern (HP:0011008) | 2.00392755 |
| 90 | Insidious onset (HP:0003587) | 2.00392755 |
| 91 | Absent speech (HP:0001344) | 1.98982887 |
| 92 | Rigidity (HP:0002063) | 1.98061562 |
| 93 | Apathy (HP:0000741) | 1.95260277 |
| 94 | Obstructive sleep apnea (HP:0002870) | 1.93855506 |
| 95 | * Mutism (HP:0002300) | 1.93603403 |
| 96 | Gait ataxia (HP:0002066) | 1.93515651 |
| 97 | * Tetraplegia (HP:0002445) | 1.92919206 |
| 98 | Sudden death (HP:0001699) | 1.91903921 |
| 99 | Spinal canal stenosis (HP:0003416) | 1.88405504 |
| 100 | Inappropriate behavior (HP:0000719) | 1.88319054 |
| 101 | Rapidly progressive (HP:0003678) | 1.87725100 |
| 102 | Lower limb amyotrophy (HP:0007210) | 1.84900087 |
| 103 | Inability to walk (HP:0002540) | 1.84510144 |
| 104 | * Excessive salivation (HP:0003781) | 1.84023172 |
| 105 | * Drooling (HP:0002307) | 1.84023172 |
| 106 | * Craniofacial dystonia (HP:0012179) | 1.83031239 |
| 107 | Syncope (HP:0001279) | 1.82937188 |
| 108 | Scotoma (HP:0000575) | 1.82695406 |
| 109 | Slow progression (HP:0003677) | 1.82472213 |
| 110 | Hand muscle atrophy (HP:0009130) | 1.82440863 |
| 111 | Abnormal atrioventricular conduction (HP:0005150) | 1.81923242 |
| 112 | Psychosis (HP:0000709) | 1.79033953 |
| 113 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.78971432 |
| 114 | Delusions (HP:0000746) | 1.77299717 |
| 115 | * Incomplete penetrance (HP:0003829) | 1.77122002 |
| 116 | Prolonged QT interval (HP:0001657) | 1.76217392 |
| 117 | Neoplasm of the heart (HP:0100544) | 1.75244519 |
| 118 | Akinesia (HP:0002304) | 1.74594735 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 1.74255448 |
| 120 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74255448 |
| 121 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74153453 |
| 122 | * Hemiplegia (HP:0002301) | 1.72031839 |
| 123 | Hypoventilation (HP:0002791) | 1.71614345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.29196288 |
| 2 | NTRK3 | 4.25137396 |
| 3 | EPHA4 | 3.74146881 |
| 4 | MARK1 | 3.41175811 |
| 5 | MINK1 | 2.92770495 |
| 6 | MAP3K4 | 2.86633141 |
| 7 | PAK6 | 2.77785952 |
| 8 | DAPK2 | 2.43291491 |
| 9 | NTRK2 | 2.34304973 |
| 10 | PRKD3 | 2.31118221 |
| 11 | MAP2K7 | 2.21500822 |
| 12 | KSR2 | 2.19674633 |
| 13 | CAMKK1 | 2.19651297 |
| 14 | NTRK1 | 1.90289847 |
| 15 | STK38 | 1.84079489 |
| 16 | MAP2K4 | 1.79755686 |
| 17 | MAP3K12 | 1.63047025 |
| 18 | CDK5 | 1.61243924 |
| 19 | KSR1 | 1.53497758 |
| 20 | RIPK4 | 1.40885925 |
| 21 | GRK5 | 1.35441294 |
| 22 | PRPF4B | 1.32670222 |
| 23 | DAPK1 | 1.31348800 |
| 24 | FES | 1.29625765 |
| 25 | SIK2 | 1.29375266 |
| 26 | PHKG1 | 1.25990289 |
| 27 | PHKG2 | 1.25990289 |
| 28 | PRKCG | 1.24546915 |
| 29 | MAP3K13 | 1.24099426 |
| 30 | TAOK1 | 1.23825158 |
| 31 | PLK2 | 1.22041005 |
| 32 | ARAF | 1.21977261 |
| 33 | TNIK | 1.21497822 |
| 34 | CDK19 | 1.21201714 |
| 35 | UHMK1 | 1.20017778 |
| 36 | LATS2 | 1.18794068 |
| 37 | ALK | 1.18565798 |
| 38 | TYRO3 | 1.18541986 |
| 39 | CAMKK2 | 1.16127373 |
| 40 | MAPK13 | 1.14475378 |
| 41 | PRKCH | 1.12651584 |
| 42 | CAMK1 | 1.10912304 |
| 43 | PINK1 | 1.06820906 |
| 44 | NEK1 | 1.05412994 |
| 45 | MAP3K2 | 1.04543425 |
| 46 | RIPK1 | 1.03825369 |
| 47 | CDK15 | 1.01289755 |
| 48 | CDK18 | 1.00964276 |
| 49 | STK11 | 0.99362521 |
| 50 | LMTK2 | 0.95589340 |
| 51 | CDK14 | 0.94589772 |
| 52 | SGK494 | 0.93727814 |
| 53 | SGK223 | 0.93727814 |
| 54 | PNCK | 0.88985645 |
| 55 | CDK11A | 0.88760220 |
| 56 | CAMK2A | 0.83408753 |
| 57 | RET | 0.83191346 |
| 58 | PAK3 | 0.80802889 |
| 59 | PKN1 | 0.80652631 |
| 60 | DYRK1A | 0.77607895 |
| 61 | SGK3 | 0.76967440 |
| 62 | TNK2 | 0.76904900 |
| 63 | MARK2 | 0.75447540 |
| 64 | RAF1 | 0.74316873 |
| 65 | SGK2 | 0.70664900 |
| 66 | CASK | 0.70265955 |
| 67 | PDK1 | 0.68533848 |
| 68 | LIMK1 | 0.67622766 |
| 69 | SCYL2 | 0.66774541 |
| 70 | SGK1 | 0.66058775 |
| 71 | CAMK1G | 0.64133086 |
| 72 | MAP3K1 | 0.61998564 |
| 73 | CDC42BPA | 0.60665369 |
| 74 | CAMK2B | 0.60462344 |
| 75 | PDPK1 | 0.59623973 |
| 76 | MAP3K7 | 0.59009789 |
| 77 | BRSK1 | 0.58822082 |
| 78 | CSNK1G2 | 0.57617382 |
| 79 | RPS6KA3 | 0.56809744 |
| 80 | BRAF | 0.55925991 |
| 81 | PRKCZ | 0.55463623 |
| 82 | WNK1 | 0.54971641 |
| 83 | CAMK4 | 0.53605487 |
| 84 | TESK1 | 0.52938991 |
| 85 | NEK6 | 0.52910315 |
| 86 | MAP3K11 | 0.52742800 |
| 87 | FGFR2 | 0.52038385 |
| 88 | FYN | 0.50813466 |
| 89 | MAPK10 | 0.50670385 |
| 90 | PTK2B | 0.48683943 |
| 91 | OXSR1 | 0.48461128 |
| 92 | CAMK2G | 0.41016681 |
| 93 | CAMK2D | 0.39196468 |
| 94 | RPS6KA2 | 0.37495834 |
| 95 | FER | 0.37168286 |
| 96 | ICK | 0.36915876 |
| 97 | PRKCE | 0.36043623 |
| 98 | PRKCB | 0.34736182 |
| 99 | ERBB2 | 0.34064969 |
| 100 | DAPK3 | 0.31426522 |
| 101 | ROCK1 | 0.31353460 |
| 102 | ROCK2 | 0.30687791 |
| 103 | MAPK12 | 0.30538965 |
| 104 | WNK3 | 0.30527139 |
| 105 | PRKCA | 0.29451788 |
| 106 | MAPK8 | 0.29381465 |
| 107 | BMPR2 | 0.29370948 |
| 108 | BMX | 0.29192262 |
| 109 | DYRK2 | 0.28542269 |
| 110 | SRC | 0.26102464 |
| 111 | GSK3B | 0.24734701 |
| 112 | CSNK1E | 0.24624561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.75928724 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.62006186 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.93908035 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.85288182 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.74605673 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.63009468 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.57982576 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.55163825 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.50193901 |
| 10 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28298735 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.24512304 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.08983690 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07984673 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.95817655 |
| 15 | * Insulin secretion_Homo sapiens_hsa04911 | 1.93860582 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89943697 |
| 17 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.80872505 |
| 18 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67917028 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65058819 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.61839557 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.58584134 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.57663707 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55940293 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.54867854 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51717018 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49339685 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48815312 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44739214 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.44649107 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36562533 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.32241222 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30061123 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29210353 |
| 34 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25023376 |
| 35 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24008215 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19740832 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16244890 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14470028 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.13380452 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10656501 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03193722 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.01301281 |
| 43 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00753537 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98782791 |
| 45 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96551026 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.95331095 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90994015 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87795204 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85483994 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85368960 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79942762 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79442123 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77041357 |
| 54 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74904324 |
| 55 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.74254440 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73085075 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70746745 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70458737 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68131067 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67063676 |
| 61 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66688557 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63494539 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62882651 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61975573 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.60395368 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59615984 |
| 67 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56090957 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55086172 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54657009 |
| 70 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54439731 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52788720 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52690568 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52316823 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52289634 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51428843 |
| 76 | * Bile secretion_Homo sapiens_hsa04976 | 0.51387850 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51290099 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50719448 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50437995 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.49921341 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49353365 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47396402 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47287696 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47024778 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45659039 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45537046 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44981334 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.43195001 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42312321 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41638608 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40815218 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40364589 |
| 93 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.39471256 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39418634 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37620879 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36141704 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35190115 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.35118106 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34996840 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34502969 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32949898 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32791475 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32486651 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31749237 |
| 105 | Tight junction_Homo sapiens_hsa04530 | 0.30852248 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29753771 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28830618 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28642230 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23818044 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23659623 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.21817156 |

